CDSCO New Drug Approval Rules 2025 – Faster Clearance Timeline
June 28, 2025
The CDSCO Rules for New Drugs 2025 have officially come into effect, marking a major reform in India’s pharmaceutical regulatory framework. The Central Drugs Standard Control Organisation (CDSCO) has overhauled its drug approval process to reduce delays, promote innovation, and ... Read more
New Pharma Manufacturing Hubs 2025 – State-Wise Cluster Expansion
June 28, 2025
The Pharma Manufacturing Hubs 2025 initiative is transforming India’s pharmaceutical production landscape with state-of-the-art industrial clusters across the country. Under the Atmanirbhar Bharat and Pharma Vision 2047 programmes, the Government of India has announced the operational rollout of several new ... Read more
India’s Bulk Drug Import 2025 – Top Countries & Industry Impact
June 28, 2025
The Indian Pharma Bulk Drug Import 2025 landscape reveals some critical trends in sourcing, cost dynamics, and dependency on global suppliers. Despite India being a global leader in generic drug manufacturing, a significant portion of Active Pharmaceutical Ingredients (APIs) and ... Read more
Pharma Innovation Fund India 2025 – ₹1500 Cr Scheme Details & Benefits
June 28, 2025
The Government of India has officially launched the Pharma Innovation Fund India 2025, allocating ₹1500 crore to fuel pharmaceutical research and development across the country. This strategic initiative is aimed at boosting India’s self-reliance in drug discovery, biotechnology, and formulation ... Read more
API Import Duty Change from August 2025 – Impact on Pharma Industry
June 27, 2025
The Government of India has officially announced a significant change in API Import Duty India 2025, effective from August. This move is a part of the larger policy to promote domestic manufacturing of Active Pharmaceutical Ingredients (APIs) under the Atmanirbhar ... Read more
Bulk Drug Park Scheme – June 2025 Subsidy and State-wise Allocation
June 27, 2025
The Government of India has released a major update in June 2025 regarding its ambitious Bulk Drug Park Scheme, a cornerstone of India’s pharmaceutical self-reliance strategy. Under this scheme, the government has sanctioned fresh subsidy allocations to three key states ... Read more
NLEM 2025 List Released – Newly Added Essential Medicines Explained
June 27, 2025
The Indian government has officially released the NLEM List 2025, marking a crucial development in the country’s healthcare affordability and accessibility. The National List of Essential Medicines (NLEM) is updated by the Ministry of Health and Family Welfare to reflect ... Read more
India’s Pharma Export 2025 – Top Markets & Growth Trends Revealed
June 27, 2025
India continues to solidify its position as the pharmacy of the world with remarkable progress in Pharma Export India 2025. The country has seen a sharp rise in exports of pharmaceutical formulations, bulk drugs (APIs), and biotechnology products, crossing new ... Read more
Jan Aushadhi Medicine List 2025 – Updated Price & Availability
June 27, 2025
The government of India has released the Jan Aushadhi Medicine List 2025, bringing updated prices and expanded availability of essential generic medicines across the country. Under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), the Ministry of Chemicals and Fertilizers continues ... Read more